Diabetes risk evaluation and microalbuminuria (DREAM) studies: Ten years of participatory research with a First Nation's home and community model for type 2 diabetes care in northern Saskatchewan

International Journal of Circumpolar Health

Volumn 67, Issue 2-3, 2008, Pages 190-202

  Pylypchuk, George ^a   Vincent, Lloyd ^b   Wentworth, Joan ^c   Kiss, Alexander ^b   Perkins, Nancy ^b   Hartman, Susan ^c   Ironstand, Laurie ^c   Hoppe, Jacqueline ^c   Tobe, Sheldon W ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c Miwayawin Health Services   (Canada)

Author keywords

Aboriginal health; Chronic disease management; Diabetes prevention; End stage renal disease; Home care nursing; Hypertension; Participatory research; Systems change

Indexed keywords

EID: 46149126893     PISSN: 12399744     EISSN: None     Source Type: Journal    
DOI: 10.3402/ijch.v67i2-3.18264     Document Type: Article

References (26)

1. Young TK, Reading J, Elias B, O'Neil JD. Type 2 diabetes mellitus in Canada's first nations: status of an epidemic in progress. CMAJ 2000;163(5):561-566.
2. Mao Y, Moloughney BW, Semenciw RM, Morrison HI. Indian Reserve and registered Indian mortality in Canada. Can J Public Health 1992;83(5):350-353.
3. Harris SB, Gittelsohn J, Hanley A, Barnie A, Wolever TM, Gao J et al. The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care 1997;20(2):185-187.
4. Harris SB, Zinman B. Primary prevention of type 2 diabetes in high-risk populations. Diabetes Care 2000; 23(7):879-881.
5. Hanley AJ, Harris SB, Mamakeesick M, Goodwin K, Fiddler E, Hegele RA, et al. Complications of Type 2 Diabetes Among Aboriginal Canadians: prevalence and associated risk factors. Diabetes Care 2005;28(8): 2054-2057.
6. Lee JS, Lu M, Lee VS, Russell D, Bahr C, Lee ET. Lower-extremity amputation: incidence, risk factors, and mortality in the Oklahoma Indian Diabetes Study. Diabetes 1993;42(6):876.
7. Anand SS, Yusuf S, Jacobs R, Davis AD, Yi Q, Gerstein H, et al. Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP). Lancet 2001;358(9288): 1147-1153.
8. Macaulay AC, Montour LT, Adelson N. Prevalence of diabetic and atherosclerotic complications among Mohawk Indians of Kahnawake, PQ. CMAJ 1988;139(3): 221-224.
9. Shah BR, Hux JE, Zinman B. Increasing rates of ischemic heart disease in the native population of Ontario, Canada. Arch Intern Med 2000;160(12):1862-1866.
10. Dyck RF, Tan L. Rates and outcomes of diabetic end-stage renal disease among registered native people in Saskatchewan. CMAJ 1994;150(2):203-208.
11. Ross SA, Flick GF. Insulin as a risk factor for diabetes complications. Diabetes 1991;40(Suppl 1):333A.
12. Ho LS, Gittelsohn J, Harris SB, Ford E. Development of an integrated diabetes prevention program with First Nations in Canada. Health Promot Int 2006;21(2): 88-97.
13. Daniel M, Green LW, Marion SA, Gamble D, Herbert CP, Hertzman C, et al. Effectiveness of community-directed diabetes prevention and control in a rural Aboriginal population in British Columbia, Canada. Soc Sci Med 1999;48(6):815-832.
14. Macaulay AC, Paradis G, Potvin L, Cross EJ, Saad-Haddad C, McComber A, et al. The Kahnawake Schools Diabetes Prevention Project: intervention, evaluation, and baseline results of a diabetes primary prevention program with a native community in Canada. Prev Med 1997;26(6):779-790.
15. Tookenay VF. Improving the health status of aboriginal people in Canada: new directions, new responsibilities. CMAJ 1996; 155(11):1581-1583.
16. Shah BR, Hux JE, Laupacis A, Zinman B, van Walraven C. Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians? Diabetes Care 2005;28(3):600-606.
17. UK Prospective Diabetes Study Group. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ 1998;317(7160):720-726.
18. Meltzer S, Leiter L, Daneman D, Gerstein HC, Lau D, Ludwig S, et al. 1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. CMAJ 1998;159(Suppl 8):S1-29.
19. Hoy WE, Baker PR, Kelly AM, Wang Z. Reducing premature death and renal failure in Australian aboriginals. A community-based cardiovascular and renal protective program. Med J Aust 2000;172(10):473-478.
20. Tobe SW, Pylypchuk G, Wentworth J, Kiss A, Szalai JP, Perkins N et al. Effect of nurse-directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: the Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomized controlled trial. CMAJ 2006;174(9):1267-1271.
21. Zanchetti A, Hansson L, Menard J, Leonetti G, Rahn KH, Warnold I et al. Risk assessment and treatment benefit in intensively treated hypertensive patients of the hypertension Optimal Treatment (HOT) study. J Hypertens 2001;19(4):819-825.
22. Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1989;13(5 Suppl):180-193.
23. Reading J. The Canadian Institutes of Health Research, Institute of Aboriginal People's Health: a global model and national network for Aboriginal health research excellence. Can J Public Health 2003;94(3):185-189.
24. Salisbury C, Fahey T. Overcoming clinical inertia in the management of hypertension. CMAJ 2006;174(9): 1285-1286.
25. Reading J. The quest to improve Aboriginal health. CMAJ 2006;174(9):1233,1237.
26. Reading J, Nowgesic E. Improving the health of future generations: the Canadian Institutes of Health Research Institute of Aboriginal Peoples' Health. Am J Public Health 2002;92(9):1396-1400.